MG 119 Gemcitabine, [cytosine-2-13C-1,3-15N2, 99 atom % 13C, 99 atom % 15N2]-
|
|
(2'-Deoxy-2',2'-difluorocytidine, [cytosine-2-13C-1,3-15N2,
99 atom % 13C, 99 atom % 15N2]- |
|
MORpure™
HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram |
|
Solid |
|
| Screw cap v-vial |
0.5 mg $930 |
| |
1 mg $1555 |
M.W. 266.2
 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MC 2246 Gemcitabine, [cytosine-2-14C]-
|
|
Click here for Typical
Certificate of Analysis |
|
(2'-Deoxy-2',2'-difluorocytidine, [cytosine-2-14C]- |
|
MORpure™
HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram |
|
Ethanol:water (1:1) solution, 100 µCi/ml |
50 µCi (1.85 MBq) $3970 |
| > 50 mCi(1.85 GBq)/mmol |
100
µCi (3.7 MBq) $5385 |
| NextGen V-Vial -
shipped on dry ice |
M.W. 263.20
 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MT 1572 Gemcitabine, [cytosine-5-3H(N)]-
Click here for Typical Certificate of Analysis
|
|
(2'-Deoxy-2',2'-difluorocytidine, [cytosine-5-3H(N)]-) |
|
Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
| Ethanol:water (1:1) solution, 1 mCi/ml |
|
> 5 Ci(185 GBq)/mmol |
50
µCi (1.85 MBq) $1195 |
| NextGen V-Vial -
shipped on dry ice |
1 mCi (37 MBq) $2350 |
| M.W. 263.20 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
